2. Huxley, R., et al., Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer, 2005. 92(11): p. 2076-83.
3. Larsson, S.C., N. Orsini, and A. Wolk, Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst, 2005. 97(22): p. 1679-87.
4. Larsson, S.C., et al., Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia, 2006. 49(12): p. 2819-23.
5. El-Serag, H.B., H. Hampel, and F. Javadi, The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol, 2006. 4(3): p. 369-80.
6. Larsson, S.C., C.S. Mantzoros, and A. Wolk, Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 2007. 121(4): p. 856-62.
7. Friberg, E., et al., Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia, 2007. 50(7): p. 1365-74.
8. Mitri, J., J. Castillo, and A.G. Pittas, Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes care, 2008. 31(12): p. 2391-2397.
9. Larsson, S.C. and A. Wolk, Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia, 2011. 54(5): p. 1013-8.
10. Giovannucci, E., et al., Diabetes and Cancer. Diabetes Care, 2010. 33(7): p. 1674.
11. Wu, D., et al., Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature, 2018. 559(7715): p. 637-641.
12. Jiang, J., et al., Oncogenic activity of insulin in the development of non-small cell lung carcinoma. Oncology letters, 2018. 15(1): p. 447-452.
13. Karlstad, O., et al., Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Current drug safety, 2014. 8(5): p. 333-348.
14. Pollak, M., Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 2008. 8(12): p. 915-28.
15. Renehan, A.G., et al., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 2004. 363(9418): p. 1346-53.
16. Pollak, M.N., E.S. Schernhammer, and S.E. Hankinson, Insulin-like growth factors and neoplasia. Nature Reviews Cancer, 2004. 4(7): p. 505-518.
17. Yu, H., D. Pardoll, and R. Jove, STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 2009. 9(11): p. 798-809.
18. Yang, Y.X., S. Hennessy, and J.D. Lewis, Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology, 2004. 127(4): p. 1044-50.
19. Currie, C.J., C.D. Poole, and E.A. Gale, The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia, 2009. 52(9): p. 1766-77.
20. Lewis, J.D., et al., Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care, 2011. 34(4): p. 916-22.
【声明】本原创内容作为知识分享和信息交流,仅代表个人观点。由于每个人身体状况及患病情况存在差异,文章内容不可取代专业医疗建议。请大家根据自身健康状况理智作出选择。
看完就完事啦?

原创不易,觉得好看
记得点个赞再走哦~
如果觉得有用,
一键“转发”让更多人看到吧~